Nizamudin, M.; Kumar, M. P.; Gautham, A.; Sriram, D. K.; George, M. Roflumilast: First Approved Oral Selective PDE4 Inhibitor for the Treatment of COPD. Int. J. Heal. Clin. Res. 2020, 3, 85-89.